Apexigen Stock

Q: Can you buy Apexigen stock?

You can no longer buy Apexigenstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

apexigen.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $165.38MM

Apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by APXiMAB™, the Company’s proprietary antibody drug discovery platform.

Learn more about Apexigen IPO

Enterprise Value

Access valuation and stock price for companies like Apexigen before its M&A.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Apexigen stock FAQs

Can you buy Apexigen stock?

You can no longer buy Apexigen stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Apexigen stock?

To invest in a private company like Apexigen through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Apexigen stock?

You can no longer sell stock of Apexigen on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Apexigen stock?

If you hold private company shares of Apexigen - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Apexigen stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Apexigen a public company?

No, Apexigen is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Apexigen’s stock price?

The stock price of Apexigen is $0.3851 as of 8/22/23.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Amy Wong

Vice President, Finance

Ovid Trifan MD

Chief Medical Officer

Xiaodong Yang Ph.D

Chief Executive Officer, President and Board Member

Mark Nevins

Vice President of Business Development

Frances Rena Bahjat Ph.D

Vice President of Discovery Research

Board Members

Herb Cross

William Rutter Ph.D

Dan Zabrowski Ph.D

Decheng Capital

George Lee Ph.D

Amkey Ventures

Xiaodong Yang Ph.D

Karen Liu Ph.D

3E Bioventures Capital

Kenneth Fong Ph.D

Kenson Ventures

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.